UK markets close in 2 hours 16 minutes

Bio-Works Technologies AB (publ) (BIOWKS.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
2.7900-0.0300 (-1.06%)
As of 02:56PM CEST. Market open.
Currency in SEK

Valuation measures4

Market cap (intra-day) 109.92M
Enterprise value 70.54M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.32
Price/book (mrq)2.50
Enterprise value/revenue 1.61
Enterprise value/EBITDA -14.22

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-82.96%
S&P500 52-week change 326.43%
52-week high 317.2000
52-week low 32.6700
50-day moving average 33.9522
200-day moving average 36.7920

Share statistics

Avg vol (3-month) 333.11k
Avg vol (10-day) 318.95k
Shares outstanding 538.98M
Implied shares outstanding 638.98M
Float 824.76M
% held by insiders 143.78%
% held by institutions 15.19%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -129.45%
Operating margin (ttm)-125.13%

Management effectiveness

Return on assets (ttm)-46.75%
Return on equity (ttm)-101.72%

Income statement

Revenue (ttm)43.9M
Revenue per share (ttm)1.22
Quarterly revenue growth (yoy)-5.80%
Gross profit (ttm)N/A
EBITDA -56.89M
Net income avi to common (ttm)-56.82M
Diluted EPS (ttm)-1.6200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)39.38M
Total cash per share (mrq)1.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.29
Book value per share (mrq)1.13

Cash flow statement

Operating cash flow (ttm)-58.99M
Levered free cash flow (ttm)-38.97M